Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Molecular Partners AG - American Depositary Shares
(NQ:
MOLN
)
4.130
+0.100 (+2.48%)
Streaming Delayed Price
Updated: 2:07 PM EST, Nov 12, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
59,089
Open
4.180
Bid (Size)
3.920 (300)
Ask (Size)
4.510 (100)
Prev. Close
4.030
Today's Range
3.980 - 4.460
52wk Range
3.360 - 6.187
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Molecular Partners Presents New Data for DLL3 Targeting Radiotherapy MP0712 at TRP Summit Europe 2025, Highlighting Initial Human Images and Mechanism of Action
Today 1:00 EST
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners to present updated data from Phase 1/2a trial of MP0533 in AML at ASH Annual Meeting
November 03, 2025
From
Molecular Partners
Via
GlobeNewswire
Performance
YTD
-15.2%
-15.2%
1 Month
+9.0%
+9.0%
3 Month
+16.1%
+16.1%
6 Month
+3.8%
+3.8%
1 Year
-29.0%
-29.0%
More News
Read More
Molecular Partners presents additional preclinical proof-of-concept data on logic-gated CD3 Switch-DARPin at SITC 2025
November 03, 2025
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners Reports Q3 2025 Financial Results and Clinical Progress, with DLL3-Targeting Radio-DARPin MP0712 Phase 1 Launch Expected in 2025
October 30, 2025
From
Molecular Partners
Via
GlobeNewswire
Looking Into Molecular Partners's Recent Short Interest
September 03, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 26, 2025
Via
Benzinga
EHang, Molecular Partners And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
August 26, 2025
Via
Benzinga
Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
August 26, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 25, 2025
Via
Benzinga
Molecular Partners reports financial results and highlights recent clinical pipeline progress for H1 2025
August 25, 2025
From
Molecular Partners
Via
GlobeNewswire
Earnings Scheduled For August 25, 2025
August 25, 2025
Via
Benzinga
Molecular Partners appoints Martin Steegmaier as Chief Scientific Officer to drive discovery of next-gen DARPin therapeutics
August 21, 2025
From
Molecular Partners
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
July 25, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
July 22, 2025
Via
Benzinga
Molecular Partners and Orano Med present preclinical data on mesothelin-targeting Radio-DARPin candidate MP0726 at SNMMI 2025
June 22, 2025
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners presents positive data from ongoing Phase 1/2a trial of MP0533 in AML at EHA 2025
June 11, 2025
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners Announces Planned Operational Efficiencies and Extension of Cash Runway
June 10, 2025
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners to Present at Upcoming Investor Conferences
May 19, 2025
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners Reports Financial Results and Highlights from Q1 2025
May 15, 2025
From
Molecular Partners
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
April 25, 2025
Via
Benzinga
Molecular Partners presents new preclinical data on Radio-DARPin and Switch-DARPin programs at AACR 2025
April 25, 2025
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners Announces all Board Proposals Approved at Annual General Meeting
April 16, 2025
From
Molecular Partners
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 08, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 07, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
March 28, 2025
Via
Benzinga
Frequently Asked Questions
Is Molecular Partners AG - American Depositary Shares publicly traded?
Yes, Molecular Partners AG - American Depositary Shares is publicly traded.
What exchange does Molecular Partners AG - American Depositary Shares trade on?
Molecular Partners AG - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Molecular Partners AG - American Depositary Shares?
The ticker symbol for Molecular Partners AG - American Depositary Shares is MOLN on the Nasdaq Stock Market
What is the current price of Molecular Partners AG - American Depositary Shares?
The current price of Molecular Partners AG - American Depositary Shares is 4.130
When was Molecular Partners AG - American Depositary Shares last traded?
The last trade of Molecular Partners AG - American Depositary Shares was at 11/12/25 02:07 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.